{
    "project_id": "170855",
    "broad_study_type": "observational",
    "narrow_study_type": "cohort_study",
    "trial_phase": "N/A",
    "observational_timeframe": "longitudinal",
    "justification": "recruiting HIV-1 infected subjects who are long term non-progressors and patients who have a normal disease progression, to study how various factors such as the type of virus they are infected with, their immune system, or their cells, help them to control the infection",
    "data_type": "canadian",
    "ipd_used": "individual",
    "novelty_statement": "Learning more about such mechanisms may be very important to help designing vaccines and/or new therapies or prevention strategies for HIV.",
    "replication_study": "no",
    "target_population_size": "N/A",
    "age_range": "adults",
    "gender_focus": "unclear",
    "vulnerable_populations": "yes",
    "rare_disease": "no",
    "population_description": "HIV-1 infected long-term non-progressors and normal progressors",
    "intervention_category": "N/A",
    "intervention_name": "N/A",
    "control_type": "comparison_groups",
    "dose_response": "no",
    "combination_therapy": "no",
    "personalized_medicine": "yes",
    "primary_outcome": "virological and host determinants of HIV disease progression",
    "primary_outcome_type": "biomarker",
    "safety_focus": "no",
    "quality_of_life": "yes",
    "biomarker_endpoints": "yes",
    "time_to_event": "yes",
    "composite_endpoint": "yes",
    "ai_machine_learning": "no",
    "digital_health": "no",
    "telemedicine": "no",
    "wearable_technology": "no",
    "big_data_analytics": "no",
    "blockchain": "no",
    "cost_effectiveness": "no",
    "budget_impact": "no",
    "health_technology_assessment": "no",
    "resource_utilization": "no",
    "productivity_outcomes": "no",
    "implementation_science": "no",
    "policy_evaluation": "no",
    "health_system_integration": "no",
    "scalability_assessment": "no",
    "barrier_identification": "no",
    "adaptive_design": "no",
    "bayesian_methods": "no",
    "machine_learning_analysis": "no",
    "novel_biostatistics": "no",
    "patient_reported_outcomes": "yes",
    "real_world_evidence": "yes",
    "industry_partnership": "no",
    "patient_engagement": "yes",
    "community_based": "no",
    "indigenous_collaboration": "no",
    "international_collaboration": "no",
    "international_network": "no",
    "regulatory_pathway": "no",
    "ethics_focus": "no",
    "consent_innovation": "no",
    "data_sharing": "no",
    "therapeutic_area": "infectious_disease",
    "disease_stage": "chronic",
    "comorbidity_focus": "yes",
    "pandemic_related": "no",
    "environmental_health": "no",
    "social_determinants": "yes",
    "health_equity": "yes",
    "climate_health": "no",
    "urban_rural": "unclear",
    "biobank_use": "yes",
    "registry_linkage": "no",
    "cohort_establishment": "yes",
    "platform_trial": "no",
    "study_duration": "long_term",
    "multicenter": "yes",
    "healthcare_setting": "outpatient",
    "disease_area": "HIV infection",
    "methodology_innovation": "comparing long-term non-progressors with normal progressors to understand mechanisms of HIV control",
    "knowledge_translation_focus": "yes",
    "equity_considerations": "yes"
} 